CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AngioLab Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AngioLab Inc
122, 159, 65, Techno 3-ro, Yuseong-gu
Phone: +82 428675785p:+82 428675785 DAEJEON, 34016  South Korea Ticker: 251280251280
Business Summary
AngioLab Inc is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The Company is principally engaged in the development, research, manufacture and sale of health functional food ingredients such as lemon balm extract mixed powder and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Min YeongKim 66
Chief Financial Officer, Managing Director Gwan SikSeo 63 1/1/2016 1/1/2016
Managing Director Yil HwanCho 62
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 16 (As of 12/31/2023)
Outstanding Shares: 2,989,678 (As of 2/20/2024)
Shareholders: 346
Stock Exchange: KON
Fax Number: +82 428675787


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024